课题基金 / 基金详情

Diabetes, Endocrinology and Metabolism Training Grant

Diabetes, Endocrinology and Metabolism Training Grant
糖尿病、内分泌学和代谢培训补助金
批准号:
10628359
负责人:
Justin Pierce Annes
金额:
$29.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1976
资助国家:
美国
项目状态:
未结题
起止时间:
1976-07-01 至 2028-06-30

项目摘要

项目成果

Justin Pierce Annes的其他基金

相似基金

相关文献

中文摘要
翻译
项目摘要 斯坦福大学的T32糖尿病、内分泌学和代谢培训项目(内分泌T32) 服务于国家需要培训医生和基础科学家在糖尿病,内分泌学和 新陈代谢.内分泌T32有着46年的严格科学训练记录;生产 众多当前和新兴的内分泌研究领导者。这次复兴的目标是坚定不移地追求这一点。 关键目的。内分泌T32,糖尿病,内分泌学唯一的博士后研究培训计划 和代谢,融入了一个非凡的研究环境,包括斯坦福大学, 糖尿病研究中心,和无与伦比的培训活动,研讨会和资源。培训计划 将提供医学博士和博士博士后学员(每年四名,平均分配),一个独特的丰富和支持 学习创新研究方法的环境。由内分泌T32支持两年,学员 将在成就卓著的研究人员和经验丰富的实验室进行尖端研究。 导师培训教师包括来自9个基础科学和临床部门的28名研究人员, 兴趣集中在四个主题(胰岛和β细胞生物学;肥胖,代谢和糖尿病并发症; 干预和人群糖尿病;内分泌学和人群健康科学);整合广泛的 以糖尿病和内分泌学为重点的实验室、临床、转化、流行病学和健康领域 差距研究。导师将参加正式的培训讲习班,以确保支持和包容 训练学员将接受结构化的学习课程,包括每周研讨会,内分泌T32 具体的系列(他们介绍和批评他人的工作)和职业相关的教学课程, 包括负责任地进行研究、生物统计学和计算/计算机编程。这些 努力培养一种激励、凝聚和富有成效的培训经验, 必须要有研究带头人。为了保障学员的成功,他们将制定职业发展 委员会评估研究进展,鼓励专业发展,并共同导航无畏 过渡到独立。在过去的15年里,85%的受训人员继续从事科学工作; 这一成功,学员将制定和提交职业奖申请,通过参与赠款写作 训练营为了表彰(医生)科学家具有挑战性的长期妊娠,稳健(每年> 30万美元) 将提供机构支助,增加受训人员的工资和过渡资金。该计划将采取 采取具体步骤,解决历史上缺乏包容性的问题,包括内部和外部咨询委员会, 在征聘和留住任职人数偏低的个人方面, 问责该培训补助金的目标是培养一批有前途的博士后(医生) 成为内分泌研究学术界、政府和工业界未来领导者的科学家。
英文摘要
Project Summary The T32 Training Program in Diabetes, Endocrinology and Metabolism at Stanford University (Endocrine T32) serves a national need to train physician and basic scientists in the fields of diabetes, endocrinology and metabolism. The Endocrine T32 has a remarkable 46-year record of rigorous scientific training; producing numerous current and emerging endocrine research leaders. The goal of this renewal is steadfast pursuit of this critical purpose. The Endocrine T32, the only postdoctoral research training program in diabetes, endocrinology and metabolism at Stanford, is integrated into an extraordinary research environment, including the Stanford Diabetes Research Center, and unparalleled training activities, seminars and resources. The training program will provide M.D. and Ph.D. postdoctoral trainees (four per year, evenly split), a uniquely rich and supportive environment to learn innovative research approaches. Supported by the Endocrine T32 for two years, trainees will pursue cutting-edge research in the laboratories of remarkably accomplished investigators and experienced mentors. The training faculty include 28 investigators from nine basic science and clinical Departments, whose interests converge on four themes (Islet and Beta-cell Biology; Obesity, Metabolism and Diabetes Complications; Interventional and Population Diabetes; Endocrinology and Population Health Sciences); integrating a wide spectrum of diabetes- and endocrinology-focused laboratory, clinical, translational, epidemiologic and health disparities research. Mentors will participate in formal training workshops to ensure supportive and inclusive training. Trainees will receive a structured curriculum of study that includes weekly seminars, an Endocrine T32 specific series (where they present and critique the work of others) and career-pertinent didactic courses, including the Responsible Conduct of Research, biostatistics and computation/computer programming. These efforts foster a stimulating, cohesive and productive training experience that engenders the knowledge and skills necessary to emerge research leaders. To safeguard trainee success, they will formulate a Career Development Committee that assesses research progress, encourages professional development and co-navigates the trepid transition to independence. Over the past 15 years, 85% of our trainees have remained in science; to continue this success, trainees will develop and submit Career Award applications through participation in grant-writing bootcamp. In recognition of the challenging, long gestation of (physician) scientists, robust (>$300,000 per year) institutional support that augments trainee salary and bridge funding will be provided. The Program will take concrete steps to address a historic lack of inclusivity, including Internal and External Advisory Committees with expertise in the recruitment and retention of underrepresented individuals and that ensure programmatic accountability. The goal of this Training Grant is to educate a diverse cadre of promising postdoctoral (physician) scientists that become the future leaders of academic, governmental and industrial in endocrine research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Developing A Platform Technology For β-Cell-Targeted Drug Delivery
  • 批准号:
    10729390
  • 项目类别:
  • 资助金额:
    $55.62万
  • 财政年份:
    2023
  • 负责人:
    Justin Pierce Annes
  • 依托单位:
Development of Beta-Cell-Targeted Regenerative Therapeutics Using A Novel Prodrug Strategy
  • 批准号:
    10215497
  • 项目类别:
  • 资助金额:
    $42.68万
  • 财政年份:
    2019
  • 负责人:
    Justin Pierce Annes
  • 依托单位:
Development of Beta-Cell-Targeted Regenerative Therapeutics Using A Novel Prodrug Strategy
  • 批准号:
    10661006
  • 项目类别:
  • 资助金额:
    $42.68万
  • 财政年份:
    2019
  • 负责人:
    Justin Pierce Annes
  • 依托单位:
Development of Beta-Cell-Targeted Regenerative Therapeutics Using A Novel Prodrug Strategy
  • 批准号:
    10453575
  • 项目类别:
  • 资助金额:
    $42.68万
  • 财政年份:
    2019
  • 负责人:
    Justin Pierce Annes
  • 依托单位:
海外基金